ConductScience.org, home

Paper8970972

Immunogenicity of an aphthovirus chimera of the glycoprotein of vesicular stomatitis virus.

Grigera PR and 4 others. J Virol, 1996. Cited by 7 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Immunogenicity of an aphthovirus chimera of the glycoprotein of vesicular stomatitis virus. Papers, record 8970972. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8970972

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Immunogenicity of an aphthovirus chimera of the glycoprotein of vesicular stomatitis virus.
PubMed
Journal
J Virol
PubMed
Year
1996
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
0.19
iCite
Revised in PubMed
2020-07-24
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Grigera PRP R
2Garcia-Briones MM
3Periolo OO
4la Torre JLJ L
5Wagner RRR R

Source PubMed

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigens, ViralMajor topic
AphthovirusMajor topic
CapsidMajor topic
Membrane GlycoproteinsMajor topic
VesiculovirusMajor topic
Viral Envelope ProteinsMajor topic
Animals
Antibodies, Viral
Baculoviridae
Capsid Proteins
Cell Line
Chlorocebus aethiops
Cricetinae
Foot-and-Mouth Disease
Genetic Vectors
Immunogenetics
Neutralization Tests
Precipitin Tests
Recombinant Fusion Proteins
Spodoptera

Source PubMed

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R37 AI 11112NIAID NIH HHSUnited StatesR37AI011112PubMed and NIH

References38

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14,118,869The glycoprotein of vesicular stomatitis virus is the antigen that gives rise to and reacts with neutralizing antibody.J Virol1972https://conductscience.org/library/papers/4118869PubMed
22,471,352Epitope mapping by deletion mutants and chimeras of two vesicular stomatitis virus glycoprotein genes expressed by a vaccinia virus vector.Virology1989https://conductscience.org/library/papers/2471352PubMed
36,176,678Location and characterization of the antigenic portion of the FMDV immunizing protein.J Gen Virol1982https://conductscience.org/library/papers/6176678PubMed
42,981,435Vaccinia virus recombinants: expression of VSV genes and protective immunization of mice and cattle.Science1985https://conductscience.org/library/papers/2981435PubMed
53,008,333Protection of cattle against foot-and-mouth disease by a synthetic peptide.Science1986https://conductscience.org/library/papers/3008333PubMed
62,543,752The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid).J Gen Virol1989https://conductscience.org/library/papers/2543752PubMed
72,155,177Neutralizing antibodies to all seven serotypes of foot-and-mouth disease virus elicited by synthetic peptides.Immunology1990https://conductscience.org/library/papers/2155177PubMed
81,690,261A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C.J Gen Virol1990https://conductscience.org/library/papers/1690261PubMed
92,157,712Heavy chain binding protein recognizes incompletely disulfide-bonded forms of vesicular stomatitis virus G protein.J Biol Chem1990https://conductscience.org/library/papers/2157712PubMed
102,163,575Isotype responses of infected, virus-vaccinated and peptide-vaccinated cattle to foot-and-mouth disease virus.Vaccine1990https://conductscience.org/library/papers/2163575PubMed
112,168,107The effect of peptides containing the arginine-glycine-aspartic acid sequence on the adsorption of foot-and-mouth disease virus to tissue culture cells.Virus Genes1990https://conductscience.org/library/papers/2168107PubMed
121,369,994Expression in yeast of amino-terminal peptide fusions to hepatitis B core antigen and their immunological properties.Biotechnology (N Y)1990https://conductscience.org/library/papers/1369994PubMed
132,234,068Product review. New mammalian expression vectors.Nature1990https://conductscience.org/library/papers/2234068PubMed
141,701,943Effect of glycosylation on the conformational epitopes of the glycoprotein of vesicular stomatitis virus (New Jersey serotype).Virology1991https://conductscience.org/library/papers/1701943PubMed
151,847,695High-affinity antibody induced by immunization with a synthetic peptide is associated with protection of cattle against foot-and-mouth disease.Immunology1991https://conductscience.org/library/papers/1847695PubMed
161,709,696Chimeric polioviruses that include sequences derived from two independent antigenic sites of foot-and-mouth disease virus (FMDV) induce neutralizing antibodies against FMDV in guinea pigs.J Virol1991https://conductscience.org/library/papers/1709696PubMed
171,653,494Two mechanisms of antigenic diversification of foot-and-mouth disease virus.Virology1991https://conductscience.org/library/papers/1653494PubMed
181,658,362Expression, processing, and assembly of foot-and-mouth disease virus capsid structures in heterologous systems: induction of a neutralizing antibody response in guinea pigs.J Virol1991https://conductscience.org/library/papers/1658362PubMed
191,312,129
Comparison between in vitro neutralization titres and in vivo protection against homologous and heterologous challenge induced by vaccines prepared from two serologically distinct variants of foot-and-mouth disease virus, serotype A22.
J Gen Virol1992https://conductscience.org/library/papers/1312129PubMed
201,312,607Protective immune response against foot-and-mouth disease.J Virol1992https://conductscience.org/library/papers/1312607PubMed

See all 38 references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
16,186,807Oncolytic activity of vesicular stomatitis virus in primary adult T-cell leukemia.Oncogene2006https://conductscience.org/library/papers/16186807PubMed
15,668,698Ex vivo generation of genetically modified dendritic cells for immunotherapy: implications of lymphocyte contamination.Gene Ther2005https://conductscience.org/library/papers/15668698PubMed
12,819,084Development of DNA vaccines against hemolytic-uremic syndrome in a murine model.Infect Immun2003https://conductscience.org/library/papers/12819084PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8970972

GET https://conductscience.org/api/papers/v1/8970972/references?page=2